Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Clover Health Investments Q4 EPS $(0.15) Misses $(0.14) Estimate, Sales $510.25M Beat $480.25M Estimate

Author: Happy Mohamed | March 12, 2024 04:52pm
Clover Health Investments (NASDAQ:CLOV) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 31.82 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $510.25 million which beat the analyst consensus estimate of $480.25 million by 6.25 percent. This is a 43.23 percent decrease over sales of $898.79 million the same period last year.

Posted In: CLOV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist